about
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humansDevelopment of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.Formulating a sulfonated antiviral dendrimer in a vaginal microbicidal gel having dual mechanisms of actionA phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jeremy Paull
@en
Jeremy Paull
@nl
type
label
Jeremy Paull
@en
Jeremy Paull
@nl
prefLabel
Jeremy Paull
@en
Jeremy Paull
@nl
P31
P496
0000-0002-9981-421X